Mukae H, Yotsuyanagi H, Ohmagari N, Doi Y, et al. Efficacy and safety of ensitrelvir in patients with mild-to-moderate COVID-19: the phase 2b part of a randomized, placebo-controlled, phase 2/3 study. Clin Infect Dis 2022 Dec 7:ciac933. doi: 10.1093.
PMID: 36477182